ES2051898T3 - Composicion farmaceutica para 4-aroilimidazol-2-onas. - Google Patents

Composicion farmaceutica para 4-aroilimidazol-2-onas.

Info

Publication number
ES2051898T3
ES2051898T3 ES89101268T ES89101268T ES2051898T3 ES 2051898 T3 ES2051898 T3 ES 2051898T3 ES 89101268 T ES89101268 T ES 89101268T ES 89101268 T ES89101268 T ES 89101268T ES 2051898 T3 ES2051898 T3 ES 2051898T3
Authority
ES
Spain
Prior art keywords
aroilimidazole
pharmaceutical composition
onas
pharmaceutically acceptable
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89101268T
Other languages
English (en)
Inventor
Jack Domet
Douglas W Danielson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2051898T3 publication Critical patent/ES2051898T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE PROPORCIONA UNA COMPOSICION FARMACEUTICA LIQUIDA QUE COMPRENDE: A) UNA CANTIDAD EFECTIVA DE 4 - AROILIMIDAZOL - 2 - ONA O UNA SAL SUYA FARMACEUTICAMENTE ACEPTABLE, Y B) UNO O MAS TENSIOACTIVOS NO IONICOS FARMACEUTICAMENTE ACEPTABLES EN PROPORCION DEL 30 AL 99% EN PESO DE LA COMPOSICION, Y OPCIONALMENTE CONTIENE ADEMAS UNO O MAS EXCIPIENTES, FARMACEUTICAMENTE ACEPTABLES, DIFERENTES DE LOS TENSIOACTIVOS NO IONICOS EN CANTIDAD TOTAL QUE PUEDE LLEGAR HASTA EL 45% EN PESO DE LA COMPOSICION.
ES89101268T 1988-01-29 1989-01-25 Composicion farmaceutica para 4-aroilimidazol-2-onas. Expired - Lifetime ES2051898T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14980388A 1988-01-29 1988-01-29

Publications (1)

Publication Number Publication Date
ES2051898T3 true ES2051898T3 (es) 1994-07-01

Family

ID=22531858

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89101268T Expired - Lifetime ES2051898T3 (es) 1988-01-29 1989-01-25 Composicion farmaceutica para 4-aroilimidazol-2-onas.

Country Status (17)

Country Link
EP (1) EP0326103B1 (es)
JP (1) JPH01226817A (es)
KR (1) KR890011594A (es)
CN (1) CN1035242A (es)
AR (1) AR241632A1 (es)
AT (1) ATE78161T1 (es)
AU (1) AU611757B2 (es)
DE (1) DE68902056T2 (es)
DK (1) DK169566B1 (es)
ES (1) ES2051898T3 (es)
GR (1) GR3005792T3 (es)
HU (1) HUT49282A (es)
IE (1) IE62426B1 (es)
IL (1) IL89049A0 (es)
NZ (1) NZ227700A (es)
PT (1) PT89561B (es)
ZA (1) ZA89552B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2038744C (en) * 1990-03-23 2002-01-08 Yoshitomi Pharmaceutical Industries Ltd. Pharmaceutical composition containing slightly water-soluble drug
WO2005058280A2 (en) * 2003-12-12 2005-06-30 Myogen, Inc. Enoximone formulations and their use in the treatment of cardiac hypertrophy and heart failure
WO2006007213A1 (en) * 2004-06-23 2006-01-19 Myogen, Inc. Enoximone formulations and their use in the treatment of pde-iii mediated diseases
EP2581082B1 (de) 2011-10-10 2015-12-30 Carinopharm GmbH Pharmazeutische Zusammensetzung zur Behandlung von Status asthmaticus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405635A (en) * 1979-06-18 1983-09-20 Merrell Dow Pharmaceuticals Inc. 4-Aroylimidazol-2-ones and their use as pharmaceuticals
EP0031603A1 (en) * 1979-12-31 1981-07-08 American Cyanamid Company Pharmaceutical composition of matter
OA06863A (fr) * 1980-08-04 1983-02-28 Merck & Co Inc Solubilisation de l'invermectine dans l'eau.
DE3307422A1 (de) * 1983-03-03 1984-09-06 Bayer Ag, 5090 Leverkusen Fluessigzubereitungen von dihydropyridinen, ein verfahren zu ihrer herstellung, sowie ihre verwendung bei der bekaempfung von erkrankungen
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs

Also Published As

Publication number Publication date
EP0326103B1 (en) 1992-07-15
DK37589D0 (da) 1989-01-27
NZ227700A (en) 1990-09-26
IE890275L (en) 1989-07-29
DK37589A (da) 1989-07-30
AU611757B2 (en) 1991-06-20
CN1035242A (zh) 1989-09-06
IE62426B1 (en) 1995-02-08
PT89561A (pt) 1989-10-04
HUT49282A (en) 1989-09-28
EP0326103A1 (en) 1989-08-02
GR3005792T3 (es) 1993-06-07
DK169566B1 (da) 1994-12-05
DE68902056D1 (de) 1992-08-20
JPH01226817A (ja) 1989-09-11
ATE78161T1 (de) 1992-08-15
PT89561B (pt) 1994-01-31
ZA89552B (en) 1989-10-25
KR890011594A (ko) 1989-08-21
DE68902056T2 (de) 1992-12-03
AR241632A1 (es) 1992-10-30
IL89049A0 (en) 1989-08-15
AU2876889A (en) 1989-08-03

Similar Documents

Publication Publication Date Title
DE69328192D1 (de) Injizierbare Arzneizubereitungen enthaltend Taxanderivate
AR004700A1 (es) 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
ES2113127T3 (es) Derivado de androstenona.
ES2083668T3 (es) Combinaciones antiviricas que contienen analogos de nucleosidos.
ES2037752T3 (es) Utilizacion de un derivado de benzoxazol y su procedimiento de preparacion.
SE8700498L (sv) Nya farmakologiskt aktiva foreningar
CO4940450A1 (es) Formulaciones farmaceuticas que contienen voriconazol
MX9200180A (es) DERIVADOS DE LA 5H-PIRROL (3,4-b) PIRAZINA OPTICAMENTE ACTIVOS, PROCEDIMIENTO PARA SU PREPARACION Y COMPOSICION FARMACEUTICA QUE LOS CONTIENE.
ES2147238T3 (es) Nuevos analogos estructurales de la vitamina d.
EA200100541A1 (ru) Фармацевтическая композиция с модифицированным высвобождением сенсибилизатора к инсулину и других антидиабетических агентов
AR012671A1 (es) Composiciones farmaceuticas para el tratamiento o profilaxis de la constipacion, los usos de dichas composiciones y los procesos para prepararlos
ES2052603T3 (es) Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
SV2002000969A (es) Composicion parenteral reconstituible
AR246160A1 (es) Preservativo para composiciones acuosas.
MX9300628A (es) Nuevos derivados de taxano, procedimiento para su preparacion y composicion farmaceutica que los contiene.
ES2092868T3 (es) Utilizacion de derivados de la 4-tiorresorcina en unas composiciones cosmeticas o dermofarmaceuticas de accion despigmentante.
ES2051898T3 (es) Composicion farmaceutica para 4-aroilimidazol-2-onas.
ES2187489T3 (es) Composiciones farmaceuticas a base de diclofenac.
ES2080621T3 (es) Preparacion de uso cutaneo.
ATE93388T1 (de) Paracetamol enthaltende arzneizubereitung.
GB2021409A (en) Pharmaceutical composition
ES2053535T3 (es) Derivados heterociclicos de cinco miembros de n,n'-diacilhidrazinas n' sustituidas.
IT1233198B (it) Derivati di benzilidene ciclanoni,procedimento per la loro preparazione, loro impiego come agenti anti- ossidanti, composizioni cosmetiche e farmaceutiche che li contengono
ES2033181B1 (es) Una tableta o capsula de herbicida para su aplicacion en arrozales.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 326103

Country of ref document: ES